SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-040004
Filing Date
2022-11-04
Accepted
2022-11-04 16:07:03
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10043740_10q.htm   iXBRL 10-Q 1471503
2 EXHIBIT 31.1 brhc10043740_ex31-1.htm EX-31.1 13830
3 EXHIBIT 31.2 brhc10043740_ex31_2.htm EX-31.2 12198
4 EXHIBIT 32.1 brhc10043740_ex32_1.htm EX-32.1 6185
10 image00001.jpg GRAPHIC 37567
  Complete submission text file 0001140361-22-040004.txt   7140960

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rckt-20220930.xsd EX-101.SCH 48435
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20220930_cal.xml EX-101.CAL 63569
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20220930_def.xml EX-101.DEF 250893
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20220930_lab.xml EX-101.LAB 721541
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20220930_pre.xml EX-101.PRE 406030
62 EXTRACTED XBRL INSTANCE DOCUMENT brhc10043740_10q_htm.xml XML 1141794
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 221362402
SIC: 2834 Pharmaceutical Preparations